Bloomer Botanicals

01/04/2026

H**p and cannabis can help with migraines. Give it a try next time.

Migraines are not just bad headaches; they are neurologic storms in which inflammation, nerve irritation, and vascular changes activate pain loops that overwhelm the system. The ECS, our Master Regulator, helps control neural excitability, vascular tone, and inflammatory signaling. When that balance slips, migraines hit harder and more often. Cannabinoids like CBGa, CBG, and CBD are showing up in research and patient experience as tools that help the body calm those loops rather than just mask pain.

A key study published in Frontiers in Pharmacology 2020 titled Cannabinoids in Migraine: A Review of the Evidence analyzed clinical and preclinical data on cannabis and cannabinoid effects on migraine pathways. The researchers found that cannabinoids interact with serotonin receptors, TRP channels, and endocannabinoid signaling pathways involved in pain and inflammation, and that plant cannabinoids can reduce migraine frequency and intensity more consistently than a placebo in small clinical settings. Frontiers in Pharmacology 2020 confirms that cannabinoids modulate pain signaling and inflammatory triggers that are core to migraine biology.

CBGa is the plant’s primordial cannabinoid. In early research, CBGa reduces inflammatory markers, such as COX enzymes, and influences serotonin receptor activity before it decarboxylates into other molecules. For migraine pathways, that means upstream inflammatory triggers get dampened, so nerve irritation and vascular responses don’t escalate as sharply. CBGa’s role is subtle, upstream, and focused on reducing the very signals that ignite a migraine attack.

CBG brings a second layer of modulation. It interacts with TRPV1 channels and serotonin systems tied to nerve firing thresholds and pain perception. For many patients, CBG translates into a softer onset of migraine pain and reduced peak intensity by helping the nervous system resist overreaction to common triggers like light, sound, or stress.

CBD supports broader neural stability. It helps slow the breakdown of endocannabinoids like anandamide, supports serotonin signaling, and moderates inflammatory cascades tied to vascular changes and nerve sensitivity. In both clinical feedback and controlled studies, CBD has been associated with fewer migraine days and a reduction in acute severity.

None of these cannabinoids forces sedation or shuts down function. They calm the loops that amplify migraine pain so the nervous system can reset. When consumers and patients integrate CBGa, CBG, and CBD into a mindful migraine plan with hydration, sleep support, and trigger awareness, the result is often fewer attacks, lower pain peaks, and a nervous system that no longer feels at war with itself.

-Mike Robinson, The Researcher OG

01/03/2026

Happy New Year!

01/03/2026

There is more to h**p and cannabis than generally known.

Raw cannabinoids like THCa, CBGa, and CBDa are the acid forms the plant produces before heat or time converts them into their more famous counterparts. Think of them as the plant’s original blueprints - untouched, unheated, and packed with biological intent.

THCa doesn’t intoxicate until it’s decarboxylated into THC, but in its raw form, it has shown strong anti-inflammatory and neuroprotective potential. One key study, Tetrahydrocannabinolic Acid A (THCA-A) Shows Potent Neuroprotective Activity, 2012, demonstrated that THCA may help protect neurons from oxidative stress, acting through PPAR-gamma pathways and reducing inflammatory damage in neural cells.

CBGa is often called the mother of many cannabinoids because it sits at the top of the plant’s cannabinoid cascade. It has shown promise in controlling inflammation, supporting metabolism, and regulating neuro-lipid signaling. In Cannabigerolic Acid Exhibits Anti-Inflammatory Properties (2021), CBGa reduced inflammatory markers in cell models, demonstrating activity at pathways that influence immune balance without suppressing immune function.

CBDa is a powerhouse inflammation modulator and digestive system influencer. In Cannabidiolic Acid Reduces Inflammation and Pain via TRPA1 Activation, 2018, CBDa demonstrated the ability to reduce inflammatory signaling and pain by activating TRPA1 channels, which are deeply involved in tissue irritation, gut motility, and inflammatory cascades. It also interacts with serotonin receptors in ways that CBD doesn’t always match.

The value here is synergy and signaling intelligence. Raw cannabinoids interact with enzyme systems, lipid networks, and receptors involved in immunity, mood, metabolism, and neural protection, often without the side effects or tolerance pressure seen with heated or synthetic analogs. They help the ECS, our Master Regulator, lean back toward equilibrium, giving the system breathing room to regulate itself rather than forcing exaggerated receptor states.

For consumers and patients exploring cannabinoid support, the raw acids offer clarity without intoxication, and biological compatibility without the chaos of lab novelty molecules. Raw cannabinoids are not weak; they’re strategic - subtle where needed, potent where it counts, and deeply aligned with the Master Regulator’s role in restoring balance.

-Mike Robinson, The Researcher OG

12/13/2025

So true.

What consumers have gone through in the US to gain even a sliver of freedom with cannabis is something most will never fully understand. The arrests, the raids, the families torn apart, the patients forced to hide their medicine, the caregivers who risked everything to help someone in pain, that was the cost before a single legal storefront ever opened its doors.

Those early years were built on fear and hope mixed, because we were fighting for access to a plant that never should have been taken from us in the first place. We pushed forward anyway. We voted. We protested. We educated. We kept showing up even when the system refused to listen.

To have cannabis still sitting on Schedule 1 after all that history feels like an insult wrapped in bureaucracy. Schedule 1 was never about science. It was about control.

It claimed the plant had no medical use, even as thousands of patients found relief every day. It claimed danger where decades of lived experience showed otherwise.

It labeled us criminals for trying to heal. Even today, the echoes of that era shape how consumers are treated, from banking restrictions to research barriers to fear-driven policy decisions that ignore the real world.

The idea of moving cannabis to Schedule 3 gets presented as progress, but the truth is more complicated. Schedule 3 hands control to the pharmaceutical channels. It invites a level of regulation that pushes out small growers, community caregivers, and legacy operators who built this movement long before it was profitable.

It risks turning a natural plant into a prescription commodity while pushing the culture, the knowledge, and the compassion that defined the early movement to the sidelines. We do not want that because we know what happens when corporations take over. Access narrows. Prices rise.

The plant becomes something you need permission to use instead of something you grow, share, and learn from.

We fought too hard to hand cannabis over now. The plant brought many of us back to life. It does not belong behind the counters of a system that never believed in it.

-Mike Robinson, The Researcher OG

11/20/2025

We need access to both h**p and cannabis (although they are the same plant). We need regulation, not prohibition.

Your body has a master regulator — the ECS — yet most clinicians were never taught about it. 🧬
The Society of Cannabis Clinicians is working to change that through science, training, and community. 🌿📚
Follow us and become a member to be part of the movement. ✨

🌎www.cannabisclinicians.org

11/13/2025

Now that Congress has made h**p containing THC illegal again, we have one year to either make it legal again or go out of business. If you find relief from pain or sleeplessness, your options will be either get your treatment from illegal sources or go without. We will announce sales and our plans in the coming months. Meanwhile, you should buy while you can.

10/29/2025

THIS IS IMPORTANT! Congress is considering a change to the definition of “h**p” which would put our small store out of business, as well as most farmers who are growing h**p. Total THC content in products would not be able to exceed 0.2 mg. Who wants to buy that low a potency, unless you just want CBD or CBG preparations, and even the effectivity of those are enhanced by the inclusion of up to 5 mg of THC in a gummy, for instance.

The level of total THC in the plant is not legal above 0.3%, and this low level requires farmers to destroy fields testing high. I’ve heard from farmers who have lost thousands of dollars in destroyed fields.

This language is included in the Agriculture Appropriations bill being considered in committee. It could be bundled with other bills to try to open the government, and this language would be hidden by the volume at that time. We have to email our senators and representatives to let them know this language is unacceptable. The h**p industry would be killed by this change.

08/26/2025

CBD from h**p interacts with the endocannabinoid system that is in your body. It helps balance so much in the body, and therefore it can help with anxiety, stress, sleep and pain. If you are struggling with any of these issues, please come see us to find out how we can help. Our staff can educate you on the many options we have in the store, and how they can benefit you.
Open Tuesday through Friday, 10a-6p and Saturday 10a-3p, at 215 W 9th, Winfield, KS, next to Casey's Gas.

07/18/2025

Finally, there are studies being done to determine whether CBD can help people with autism who have behavior issues, including reducing aggression, hyperactivity and improve communication. There is no need to give anti-psychotic drugs and make people "stoned." We have several different strategies and products which can improve some effects of autism. Check us out at Bloomer Botanicals, 215 W 9th, Winfield (next to Casey's).

11/30/2024

We have a winner of Chamber bucks on Shop Small Saturday!

11/19/2024

CBD can do so much to help people with Pain, Anxiety, or Insomnia, among other things. This article describes the studies undertaken so far.

There are nearly 100 different cannabinoids in cannabis and h**p plants. The two primary components are THC and CBD. As research into these compounds continue, more studies show their efficacy — particularly CBD — in treating a variety of conditions.

https://theemeraldmagazine.com/the-efficacy-of-cbd-what-the-research-shows-us-so-far/

03/22/2024

The only way to make progress on legalization is to replace the legislators. Make sure you vote for people who support cannabis.